Abbott Labs Posts Higher 1Q Sales, Earnings
20 Avril 2022 - 2:20PM
Dow Jones News
By Will Feuer
Abbott Laboratories posted higher profit and sales for the first
quarter, led by a surge in diagnostics that was driven in part by
an increase in the company's global Covid-19 testing sales.
The Abbott Park, Ill.-based medical-products company logged
earnings of $1.37 a share, up from $1 a share a year earlier. Net
earnings were $2.45 billion, up from $1.79 billion a year
earlier.
Adjusted earnings were $1.73 a share. Analysts polled by FactSet
had forecast adjusted earnings of $1.47 a share.
Sales for the quarter rose to $11.9 billion from $10.46 billion
12 months ago. Analysts were expecting revenue of $10.99
billion
Nutrition sales fell 7% to $1.89 billion. Diagnostics sales were
up 32% to $5.29 billion. Medical-device revenue rose 7.4% to $3.57
billion.
Worldwide Covid-19 testing-related sales were $3.3 billion, up
from $2.19 billion a year earlier.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
April 20, 2022 08:05 ET (12:05 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Abbott Laboratories (NYSE:ABT)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024